Literature DB >> 1826985

Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans.

A Nordøy1, L Barstad, W E Connor, L Hatcher.   

Abstract

Five normolipemic subjects received three test meals containing 28 g n-3 (omega-3) fatty acids provided as 1) triglycerides, 2) ethyl esters, and 3) ethyl esters + 12 g olive oil. The control meal contained olive oil. When equivalent amounts of fat were given, the increase in chylomicron and plasma triglycerides was similar; n-3 fatty acid contents were also similar after n-3 fatty acid intake as ethyl esters or triglycerides. Ethyl esters alone were well absorbed and produced similar n-3 fatty acid responses in plasma triglycerides and chylomicrons. At 24 h after the n-3 fatty acid-containing meals, the fatty acid plasma concentration of these acids was similar. This study showed that n-3 fatty acids in fish oil given as ethyl esters or triglycerides were equally well absorbed. Eicosapentaenoic and docosahexaenoic acids were also equally absorbed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826985     DOI: 10.1093/ajcn/53.5.1185

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  35 in total

Review 1.  Fish oil for primary and secondary prevention of coronary heart disease.

Authors:  Eli M Roth; William S Harris
Journal:  Curr Atheroscler Rep       Date:  2010-01       Impact factor: 5.113

2.  Increased hepatic beta-oxidation of docosahexaenoic acid, elongation of eicosapentaenoic acid, and acylation of lysophosphatidate in rats fed a docosahexaenoic acid-enriched diet.

Authors:  A Kanazawa; Y Shirota; K Fujimoto
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

Review 3.  Is there a rational use for n-3 fatty acids (fish oils) in clinical medicine?

Authors:  A Nordøy
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

4.  Natural and accelerated docosahexaenoic acid accumulation in the prenatal rat brain.

Authors:  P Green; E Yavin
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

5.  Effects of triolein or oleic acid on lymphatic recovery of docosahexaenoic acid given as ethyl ester and their intramolecular distribution in lymph triglyceride of rats.

Authors:  I Ikeda; H Yoshida; K Imaizumi
Journal:  Lipids       Date:  1997-09       Impact factor: 1.880

6.  Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers.

Authors:  Alison H Keenan; Theresa L Pedersen; Kristi Fillaus; Mark K Larson; Gregory C Shearer; John W Newman
Journal:  J Lipid Res       Date:  2012-05-24       Impact factor: 5.922

Review 7.  Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain.

Authors:  M Lagarde; N Bernoud; N Brossard; D Lemaitre-Delaunay; F Thiès; M Croset; J Lecerf
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

8.  Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.

Authors:  Claudio Galli; Franco M Maggi; Patrizia Risé; Cesare R Sirtori
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

Review 9.  Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia.

Authors:  Sheridan M Hoy; Gillian M Keating
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

10.  Cytotoxicity of unsaturated fatty acids in fresh human tumor explants: concentration thresholds and implications for clinical efficacy.

Authors:  David E Scheim
Journal:  Lipids Health Dis       Date:  2009-12-15       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.